Vertical Targeting of AKT and mTOR as Well as Dual Targeting of AKT and MEK Signaling Is Synergistic in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the sixth most common cancer, and the third most common cause of cancer related death worldwide. The multi-kinase inhibitor Sorafenib represents the only systemic treatment option until today, and results from clinical trials with allosteric mTOR inhibitors were sob...

Descripción completa

Detalles Bibliográficos
Autores principales: Ewald, Florian, Nörz, Dominik, Grottke, Astrid, Bach, Johanna, Herzberger, Christiane, Hofmann, Bianca T., Nashan, Björn, Jücker, Manfred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622849/
https://www.ncbi.nlm.nih.gov/pubmed/26535060
http://dx.doi.org/10.7150/jca.12452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622849/
https://www.ncbi.nlm.nih.gov/pubmed/26535060
http://dx.doi.org/10.7150/jca.12452

Ejemplares similares